Newsroom

Categories: COVID-19, Clinical Research & Trials

PrecisionLife and Metrodora Institute launch clinical trials to accelerate the diagnosis and treatment of ME/CFS and Long Covid patients

May 14, 2024

Categories: Diagnostics & Hospital Laboratory, COVID-19, Corporate, Finance & Investor

PrecisionLife project awarded Innovate UK Grant to improve diagnosis and treatment of ME/CFS and Long Covid

December 15, 2023

Categories: COVID-19, Clinical Research & Trials, Corporate, Finance & Investor

NIH and Exothera collaborate to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US

August 16, 2023

Categories: Healthcare, COVID-19, Drug Discovery & Development

PrecisionLife identifies first detailed genetic risk factors for long COVID and common mechanisms with ME/CFS and other complex diseases

July 18, 2023

Categories: Biotechnology, COVID-19, Corporate, Finance & Investor

Takara Bio announces partnership for the distribution of CE-IVD solutions for respiratory tract infections

September 6, 2022

Categories: Healthcare, COVID-19

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions announce a new antibody cocktail effective against major variants of SARS-CoV-2

June 7, 2022

Categories: Biotechnology, Healthcare, COVID-19

DOLPHIN Vagus Stimulation receives Health Canada Approval for covid-19 (ARDS)

February 9, 2022

Categories: Healthcare, COVID-19

Labs Evidence : Novel Concepts Medical blocked Omicron and Coronavirus entry to human cells

February 9, 2022

Categories: COVID-19, Clinical Research & Trials

Novel Concepts Medical groundbreaking medicine successfully disrupted COVID-19 spike protein attachment into host cells, intended to stop Omicron

December 16, 2021